Cite
HARVARD Citation
Nikolic, T. et al. (2020). Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes. Lancet. 8 (6), pp. 470-472. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nikolic, T. et al. (2020). Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes. Lancet. 8 (6), pp. 470-472. [Online].